PD-L1 ImagiNg to prediCt Durvalumab Treatment Response in HNSCC
Condition(s):Head and Neck CancerLast Updated:January 7, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Head and Neck CancerLast Updated:January 7, 2021Terminated
Condition(s):Pediatric Cancer; Solid Tumor Pediatric; Hematological MalignanciesLast Updated:February 26, 2021Recruiting
Condition(s):Stage III Non-small-cell Lung CancerLast Updated:March 10, 2021Recruiting
Condition(s):SCLC, Extensive StageLast Updated:February 21, 2021Not yet recruiting
Condition(s):Bladder CancerLast Updated:November 4, 2020Recruiting
Condition(s):Advanced Hepatocellular CarcinomaLast Updated:November 12, 2020Recruiting
Condition(s):Colorectal Cancer; Solid TumorLast Updated:February 25, 2021Recruiting
Condition(s):HNSCCLast Updated:April 9, 2020Recruiting
Condition(s):Non Small Cell Lung Cancer; Renal Cell CarcinomaLast Updated:November 17, 2020Withdrawn
Condition(s):Small Cell Lung Cancer (SCLC)Last Updated:February 2, 2021Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.